The forecast includes around $6.4 billion in new spending comprised of additional funding for the new five year Community Pharmacy Agreement and new PBS listings. This could equate to between $1.5 and $2 billion in budgeted new spending for 2027-28. Yet the forecast is just $700 million higher than 2023-24. Something else is in there and more is coming. …
The Budget should leave people in no doubt that more announcements are coming
May 15, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
LifeSciences Australia honours outstanding professionals at MTP Sector Awards 2026
June 12, 2026 - - Latest News -
'The changes could cause irreversible damage to our vibrant and world-leading biotech, medtech and health tech sector'
June 12, 2026 - - Australian Biotech -
The opportunity to change the conversation, the negotiating dynamic, and take some control
June 12, 2026 - - Latest News -
State and Territory ministers warn against centralising NDIS power
June 12, 2026 - - Latest News -
ARCS evolves into LifeSciences Australia as part of wider strategic change
June 11, 2026 - - Latest News -
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - - Latest News -
Island secures US partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech